Progession of AML treatment over the past decades
Advancements in APL treatment: oral ATO, MRD and treatment objectives
Identifying patients at different risk of relapse in childhood acute lymphoblastic leukemia (ALL)
Where will leukemia research go next?
A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian